It was announced that Sunzen Biotech will be exiting from its animal health business to focus on human health products and loan financing services. Executive chairman, Ching Chee Pun shares with us the rationale behind this decision, the outlook and why they appear to have a weak track record when it comes to M&A.

Produced by: Moh Heng Ying

Presented by: Wong Shou Ning, Philip See

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  technology,  environment,  wellness,  financial wellness

Tags:  loan financing services,  human health,  financial loan,  sunzen biotech,  animal health,  mergers and acquisition,